FDA Device Intelligence
Home › KANEKA CORPORATION › LIXELLE

LIXELLE

KANEKA CORPORATION · Model S-15 · UDI-DI 14993478010059

PDI Prescription
0
510(k) clearances
27
Adverse events
0
Recalls
1
Facilities

Description

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.